Investors in Clean Energy Fuels Corp. (NASDAQ:CLNE) had a good week, as its shares rose 6.3% to close at US$2.11...

As of Thursday evening, more than 40 percent of the funds remained available in the Paycheck Protection Progam

Esperion Therapeutics, Inc. (NASDAQ:ESPR) investors will be delighted, with the company turning in some strong numbers...

The latest data analyzed by The Block Research shows that bitcoin miners made 8% more revenue in April as compared to March, thanks to a gradual recovery in bitcoin’s price.The post Bitcoin miners made $412.5 million in revenue during April, new data indicates appeared first on The Block.

The analysts might have been a bit too bullish on Consolidated Edison, Inc. (NYSE:ED), given that the company fell...

Could we see the yellow metal at $5,000 or even higher amid the coronavirus crisis? We invite you thus to read our today’s article and find out how high gold prices can go in this downturn.

When tickets for the May 11 reopening of Shanghai Disneyland went on sale, they sold out within minutes. Park officials said they are taking "a deliberate approach”, such as requiring physical distancing and sharply reducing capacity. Jen Rogers, Myles Udland and Akiko Fujita discuss what the reopening of the first major theme park says about consumer demand post-coronavirus.

The move will help Southwest save cash at a time when U.S. airlines collectively burn more than $10 billion a month. Last month, rival United Airlines agreed to sell and lease back 22 planes to aircraft investor Bank of China Aviation. United, however, did not specify the size of the deal.

Director of Fiscal Policy at the American Action Forum Gordon Gray joins Yahoo Finance’s Seana Smith to break down the April jobs report and how some workers are making more on unemployment compared to their wages before the coronavirus pandemic.

Biopharma shares have outperformed the broader market year-to-date, giving rise to apprehension over whether a pullback is in the offing. An analyst at BofA Securities said Friday that now is the time to go from defensive to offensive in the sector, as quarantines are winding down in several parts of the globe.The Biopharma Analyst Analyst Geoff Meacham shortlisted Eli Lilly And Co (NYSE: LLY), Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX), Bristol-Myers Squibb Co (NYSE: BMY), BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) and Amgen, Inc. (NASDAQ: AMGN) as biopharma stocks where he would put his money to work.The analyst has the following ratings and price targets for the shares: * Lilly: Buy/$165 * Vertex: Buy/$300 * Bristol-Myers Squibb: Buy/raised the price target from $75 to $80 * BioMarin: Buy/lifted price target from $110 to $120 * Amgen: Buy/price target increased from $265 to $2755 Reasons For BofA's Bullish Disposition BofA is increasingly bullish on the biopharma group due to the following factors, Meacham said: * Expectations for robust revenue growth of 6% in the second half of 2020 compared to the first-half, which is double that of the S&P 500's revenue growth. * Reasonable price-earnings for the stocks in the sector. * Many value-creating events lined up for the second half. * Lower policy risk stemming from goodwill earned from the COVID-19 pipeline. * A consistently positive FDA backdrop.Q1 Earnings Get 'A' Grade All of the big biotechs and major pharma companies reported both revenue and adjusted EPS beats in the first quarter, with Lilly and Vertex even raising some parts of their 2020 guidance, Meacham said.Citing slower new starts and forex headwinds, Bristol-Myers Squibb and BioMarin lowered their 2020 revenue guidance, but maintained their EPS guidance, the analyst said. Meacham expressed surprise at Merck & Co., Inc. (NYSE: MRK) and Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) lowering their 2020 revenue and adjusted EPS guidance, given his belief that oncology or orphan diseases wouldn't be as sensitive to COVID-19 disruption.See also: Attention Biotech Investors: Mark Your Calendar For These May PDUFA Dates Lilly One of The Higher Quality Stocks In BofA's Coverage Lilly is a source of differentiated growth given its early product cycle and diversified base business, including diabetes, immunology and immunotoxicology and migraine, and an advancing late-stage pipeline of potentially best-in-class or first-in-class therapies, Meacham said.The analyst said he likes Lily's potential for additional earnings growth in 2020-2021 and views Lilly as one of the higher quality stocks in his coverage despite its higher valuation. The prospects for 2021 look attractive, with selpercatinib potentially launching in non-small cell lung cancer and thyroid cancer by year's end, and tirzepatide approval in 2021 representing a "step change" for the diabetes franchise, he said. Consensus For Vertex To Move Higher? Vertex has a richer -- though well-deserved -- valuation, due to its differentiated growth profile, Meacham said.Given that Vertex's commercial execution is largely unaffected by the COVID-19 pandemic, the analyst said investors will begin to look forward to 2021 sooner than for other companies with more commercial risk.BofA expects consensus estimates to continue to move higher, making Vertex's valuation even more attractive.Bristol-Myers Has Highly Differentiated Growth With an estimated 8% revenue growth and 19% EPS growth in 2021 compared to 5-6% and 12%, respectively, for peers, and with six new launches expected this year, 2020 is shaping up to be a very robust period for Bristol-Myers despite the ongoing COVID-19 headwinds, Meacham said. The analyst said the company's growth looks highly differentiated.An increasingly diversified product mix and beatable launch expectations position the company for meaningful upside to consolidated P&L, with improving synergies, he said. BioMarin's 'Game-Changing' Late-Stage Pipeline BioMarin's late-stage pipeline in valrox and vosoritide have improved its growth outlook, Meacham said.The analyst termed the company's late-stage pipeline as "game-changing." The second-half launch of Roctavian is the most important catalyst for the company this year, with the product likely to accelerate the company's already above-average growth profile, he said. "We see BioMarin as one of the higher quality names in our coverage universe given its clean growth story and it remains our SMid cap top pick." Amgen Looks To New Product Growth To Compensate For Legacy Product Erosion The long-term outlook for Amgen's Otezla is improving given the recently announced Phase 3 data for mild-to-moderate psoriasis, Meacham said.The company rapidly refocused its story from legacy product erosion to new product growth with the acquisition of Otezla from the Bristol/Celgene deal, the analyst said. "Since then Amgen's growth profile has only improved, led by an expanded addressable market for Otezla, outperforming Amgen Biosimilars and Evenity franchises, aggressive formulary negotiation for Aimovig, and an exciting pipeline in AMG 510 and tezepelumab looking to contribute as soon as 2021." The Price Action The iShares NASDAQ Biotechnology Index (NASDAQ: IBB) was last seen trading up 1.25% to 128.76, adding to its 5.6% year-to-date gain. Related Link: The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace See more from Benzinga * The Daily Biotech Pulse: Ayala IPO, Pluristem Starts Phase 2 Trial Of COVID Treatment, European Nod For Takeda * The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500 * The Daily Biotech Pulse: FDA Nod For AstraZeneca, AbbVie-Allergan Deal Clears Antitrust Hurdle(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Retailers that were already ailing before the coronavirus are beginning to crumble as the crisis raises the threat of store closings and bankruptcy.

Moody’s Analytics analyzed U.S. metro areas capabilities for a strong recovery post-coronavirus using two primary factors: population density and educational attainment.

Many U.S. airliners are "reasonably confident" that a return to 30% to 50% of pre-COVID-19 capacity by the end of 2020 is possible, Boeing Co (NYSE: BA) CEO David Calhoun said in a Fox Business interview Friday. A 'Crawl Back' For Airline Industry Investors expecting a swift return to 2019 traffic levels may be disappointed, as the industry will "slowly crawl back" to pre-crisis levels over a three-year period, Calhoun said.It will take another two years afterward for the industry to resume the growth curve seen over the past 20 years, the CEO said. The timeline could change based on different factors, including a quicker-than-expected development of a COVID-19 vaccine that results in a "more robust" recovery, he said.Boeing 737 MAX Update The pandemic is far from Boeing's only problem to deal with, as the two 737 MAX crashes set the company back two years, Calhoun said.The company continued to manufacture new MAX planes, and even if they are grounded today, the planes will ultimately "find their way into the market."Any near-term market share losses will be erased as the MAX undergoes a "catchup" phase, he said.Boeing's talks with the FAA regarding the certification process are "constructive" and "thorough," Calhoun said.The work-from-home and travel restrictions do add by default additional time to any eventual certification for the MAX to return to the skies, the CEO said. Boeing also expects to resume 737 MAX production this month after it was suspended in January, he said. The company has already announced its plans to build fewer planes moving forward to compensate for its existing inventory.Boeing's Bond Deal Boeing already suspended its dividend and will prioritize the payback of its new $25-billion bond issue until "we get back to the same kind of balance sheet" that existed prior to the MAX crashes, he said. After that, the company will plan on how to resume cash distributions to shareholders, Calhoun said -- but not until Boeing "significantly" pays down debt. Boeing shares were trading 3.27% higher at $132.86 at the time of publication Friday.Related Links:Boeing's Large Bond Deal Solves Liquidity Problem, Says Bullish Goldman SachsBoeing Analyst Turns Bullish After Deep Sell-OffSee more from Benzinga * Southwest Airlines CEO On 'Breathtaking' March Declines, Financial Plans * Boeing Shares Lose Altitude On New Coronavirus-Driven Concerns * Carly Fiorina Blasts Corporate Bailout Funding In T Coronavirus Relief Bill(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

What happened to my stimulus money? Many who receive government benefits and others continue to wonder in early May.

Moderna CEO Stephane Bancel stated that the company’s new coronavirus vaccine, which was clear for a phase 2 trial on Thursday by the FDA, would not be ready for immediate release to the public and that the distribution of the potential vaccine would need to be handled carefully between Moderna and the White House. Yahoo Finance’s Anjalee Khemlani joins The Final Round panel to break down the latest news about the coronavirus.

A large-scale attack campaign has targeted over 900,000 WordPress websites through vulnerabilities in plugins and themes, WordPress security company Defiant revealed this week.

read more

The Czech Republic and the United States have signed a joint declaration Wednesday for cooperating on security of 5G technology.

read more

Popular communications platform provider Zoom Video announced on Thursday that it has acquired secure messaging and file-sharing service Keybase for an undisclosed sum. The move is the latest by the company as it attempts to bolster the security of its offerings and build in end-to-end encryption that can scale to the company’s massive user base.

read more

Naikon, a Chinese APT group that disappeared after its activities were disclosed in 2015, has been rediscovered and may have remained active but unrecognized since the 2015 reports. Researchers have uncovered evidence of a five-year stealth campaign against similar targets in the same geographical area that they believe to be conducted by Naikon.

read more

Recorded Future this week announced the availability of Express, a free web browser extension designed to help security teams prioritize vulnerability patching and alerts from security information and event management (SIEM) tools.

read more

Cisco’s Talos threat intelligence and research group revealed on Wednesday that one of its researchers discovered a critical remote code execution vulnerability in the CODESYS Control SoftPLC industrial controller software.

read more

Samsung this week released its May 2020 set of security updates for Android smartphones, which includes a patch for a critical vulnerability impacting all of its devices since 2014. 

read more

More than 30 technology and telecom companies announced this week that they have formed a new alliance, the Open RAN Policy Coalition, that calls for open and interoperable 5G systems.

read more

Nigerian cybercriminals specialized in business email compromise (BEC) attacks were observed leveraging COVID-19 lures in recent attacks on healthcare and government organizations, Palo Alto Networks reveals.

read more

Happy Environment Day 2016 As the title says, I would like to wish all of you an very happy environment day. Ideally speaking, every day of the year should be environment day isn’t it? You bet! Well we are definitely not in an ideal world. So we really need to think ways we can contribute to […]

What lettuce comes to your mind, when I say the word lettuce? Go on, take a minute. If you thought Iceberg lettuce, you aren’t alone. Iceberg is (or used to be) the defacto standard when it comes lettuce.  Iceberg lettuce has its crunch but if you look beyond the crunch, nutrient values that is, you will […]

TDS vs EC meter – Which one to buy? If you are a beginner in Hydroponics, it is certain, at some point, you would have had this question in your mind. Should I buy an EC meter or a TDS meter? While the users are split on which one is better, it is good to […]

Microgreens are everywhere these days. You see them in the toppings, in the garnishes and hey also in your friend’s Instagram page.   So what is so great about microgreens that makes everyone go gaga over it? The answer is very simple. More nutrition at fraction of a time! Needs very small space to grow […]

Understanding pH in Hydroponics Hydroponics is all about precision. The health of the plants in your growing system depends on various factors – design of your system, crop selection, key parameters such as pH, EC, temperature, humidity among others. These parameters have a range in which they need to be kept in order to get […]

Motorcycle Rally Grows

Underpins company plan to expand commercialization and definitive manufacturing relationships

Buying a used car online does not have to be intimidating. With these four easy tips, you can make sure that you are getting the best vehicle for your money.

Biker Next is Dating VIP's latest club that seeks to bring together everyone who's interested in biking - feel the wind and the open road with your partner!

Extreme endurance motorcycle rider to attempt 9th world record, "Greatest Distance on a Motorcycle in 24 Hours (Individual)" this weekend in Uvalde, Texas. Follow live at www.carlreese.net starting on February 24, 2017.

There is a one in three chance that a motorist will require roadside assistance in the next 12 months due to battery failure or a related electrical system issue.

Motorcycle enthusiasts can now experience another bucket-list journey of a lifetime.

Motorcycle enthusiasts are encouraged to take advantage of the European riding season and attend the world's largest BMW motorcycle party.

This marks the 3rd consecutive award the Houston personal injury firm has received for the quality of service it offers clients.

A firefighter with over 20 years' experience launched a safety tool on crowd-funding site Kickstarter that can literally be a lifesaver for First Responders and Civilians alike!

Billy Johnson of the Billy Johnson Law Firm in Pikeville, Ky., says highways are especially dangerous during summer months.

WeeTect, a global leader in designing and manufacturing abrasion resistant helmet visors, today announced that it has started using this technology on other eye and face protection products.

Indiegogo campaign will launch on September 20, 2017.

WeeTect announces its new generation of photochromic visor inserts.

Typically used on older Chevy Impala, Chevy Caprice or even Datsun 280Z, rivet on the body side molding is an add-on accessory that was installed at car dealerships over in the 70's and 80's.

Billy Johnson, a personal injury attorney in Pikeville, KY, said that a greater awareness of the threats facing motorists could reduce the number of vehicle crashes.